A team of local researchers has discovered a way to treat extensively drug-resistant tuberculosis.

In a joint study with a U.S. researcher, the International Tuberculosis Research Center injected linezolid into 41 patients with a strain of tuberculosis resistant to almost all antibiotics. Eighty-nine percent of the patients saw progress in their treatment and 41 percent fully recovered.

Linezolid had been experimentally injected to patients with extensively drug-resistant tuberculosis but the latest study was the first of its kind to confirm the actual effects of the drug on tuberculosis.

The latest study was published on renowned medical journal, the New England Journal of Medicine.